Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes.
about
Update on nasopharyngeal carcinomaSalvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience.Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay.Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosisRisk stratification based on change in plasma Epstein-Barr virus DNA load after treatment in nasopharyngeal carcinomaBreast metastasis from nasopharyngeal carcinoma: A case report and review of the literature.Molecular pathological study of the human nasopharyngeal carcinoma CNE3 cell line.Monocyte-derived factors including PLA2G7 induced by macrophage-nasopharyngeal carcinoma cell interaction promote tumor cell invasiveness.Undifferentiated carcinoma of the oropharynx: a human papillomavirus-associated tumor with a favorable prognosis.Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma.The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database.
P2860
Q33594732-6AA09881-44A5-4465-B272-C251020B9D95Q34477214-E6CD37F2-82EF-4A0B-99B7-6D91B8244C11Q35587428-E15E34F2-B8FC-4D36-B8AF-A1196C617928Q35987088-62F1C812-904C-47BB-BFF2-27A2FE6600BDQ36670981-B909E148-40C5-42BE-B5A1-A9C3BBFC3354Q36962686-A9A572EA-1951-4538-897D-0485B65D5415Q36980653-42F963E5-21E5-4144-8FA1-9A9BFFB15023Q37229370-7E11668D-460C-4ED9-A7BA-2E046CA17B32Q37688255-A0A2A6F2-1D19-4089-980C-23D85F5A10DAQ37875667-0CE7F1E6-9612-4938-8887-18BF1F403306Q40078689-F9739D6E-033D-4158-AEA6-7469DE1E66EAQ54965220-DD3D3F7F-B17B-4D85-8301-EA8CD819D642
P2860
Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Expression of EBER1 in primary ...... with WHO histologic subtypes.
@en
Expression of EBER1 in primary ...... with WHO histologic subtypes.
@nl
type
label
Expression of EBER1 in primary ...... with WHO histologic subtypes.
@en
Expression of EBER1 in primary ...... with WHO histologic subtypes.
@nl
prefLabel
Expression of EBER1 in primary ...... with WHO histologic subtypes.
@en
Expression of EBER1 in primary ...... with WHO histologic subtypes.
@nl
P2093
P1433
P1476
Expression of EBER1 in primary ...... with WHO histologic subtypes.
@en
P2093
P304
P356
10.1002/(SICI)1097-0142(19960115)77:2<231::AID-CNCR2>3.3.CO;2-C
P407
P577
1996-01-01T00:00:00Z